Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts
- PMID: 30609725
- PMCID: PMC6356674
- DOI: 10.3390/nu11010074
Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts
Abstract
The aim of this study was to determine if increased mortality associated with low levels of serum 25-hydroxyvitamin D (25(OH)D) reflects a causal relationship by using a Mendelian randomisation (MR) approach with genetic variants in the vitamin D synthesis pathway. Individual participant data from three European cohorts were harmonized with standardization of 25(OH)D according to the Vitamin D Standardization Program. Most relevant single nucleotide polymorphisms of the genes CYP2R1 (rs12794714, rs10741657) and DHCR7/NADSYN1 (rs12785878, rs11234027), were combined in two allelic scores. Cox proportional hazards regression models were used with the ratio estimator and the delta method for calculating the hazards ratio (HR) and standard error of genetically determined 25(OH)D effect on all-cause mortality. We included 10,501 participants (50.1% females, 67.1±10.1 years) of whom 4003 died during a median follow-up of 10.4 years. The observed adjusted HR for all-cause mortality per decrease in 25(OH)D by 20 nmol/L was 1.20 (95% CI: 1.15⁻1.25). The HR per 20 nmol/L decrease in genetically determined 25(OH)D was 1.32 (95% CI: 0.80⁻2.24) and 1.35 (95% CI of 0.81 to 2.37) based on the two scores. In conclusion, the results of this MR study in a combined sample from three European cohort studies provide further support for a causal relationship between vitamin D deficiency and increased all-cause mortality. However, as the current study, even with ~10,000 participants, was underpowered for the study of the effect of the allele score on mortality, larger studies on genetics and mortality are needed to improve the precision.
Keywords: Individual Participant Data; Mendelian randomization; Vitamin D; cohorts; mortality; standardized 25(OH)D.
Conflict of interest statement
Paul Lips reports a competing interest: Advice to Friesland Campina, dairy industry. All other authors have nothing to declare.
Figures
Similar articles
-
Vitamin D and mortality: a Mendelian randomization study.Clin Chem. 2013 May;59(5):793-7. doi: 10.1373/clinchem.2012.193185. Epub 2013 Jan 14. Clin Chem. 2013. PMID: 23319826
-
Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women.Nutrients. 2018 Jan 9;10(1):55. doi: 10.3390/nu10010055. Nutrients. 2018. PMID: 29315215 Free PMC article.
-
Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study.Lancet Diabetes Endocrinol. 2014 Sep;2(9):719-29. doi: 10.1016/S2213-8587(14)70113-5. Epub 2014 Jun 25. Lancet Diabetes Endocrinol. 2014. PMID: 24974252 Free PMC article.
-
Negative effect of vitamin D on kidney function: a Mendelian randomization study.Nephrol Dial Transplant. 2018 Dec 1;33(12):2139-2145. doi: 10.1093/ndt/gfy074. Nephrol Dial Transplant. 2018. PMID: 29718335 Free PMC article.
-
Vitamin D and Type 1 Diabetes Risk: A Systematic Review and Meta-Analysis of Genetic Evidence.Nutrients. 2021 Nov 26;13(12):4260. doi: 10.3390/nu13124260. Nutrients. 2021. PMID: 34959812 Free PMC article.
Cited by
-
Vitamin D supplementation for the prevention of total cancer incidence and mortality: An updated systematic review and meta-analysis.Heliyon. 2022 Oct 28;8(11):e11290. doi: 10.1016/j.heliyon.2022.e11290. eCollection 2022 Nov. Heliyon. 2022. PMID: 36345522 Free PMC article.
-
Change of vitamin D status and all-cause mortality among Chinese older adults: a population-based cohort study.BMC Geriatr. 2022 Mar 24;22(1):245. doi: 10.1186/s12877-022-02956-1. BMC Geriatr. 2022. PMID: 35331164 Free PMC article.
-
Critical Appraisal of Large Vitamin D Randomized Controlled Trials.Nutrients. 2022 Jan 12;14(2):303. doi: 10.3390/nu14020303. Nutrients. 2022. PMID: 35057483 Free PMC article. Review.
-
Serum 25-hydroxyvitamin D and risk of cancer in a large community population under investigation for cardiovascular disease: a retrospective cohort study.BMJ Open. 2022 Jan 19;12(1):e056543. doi: 10.1136/bmjopen-2021-056543. BMJ Open. 2022. PMID: 35046006 Free PMC article.
-
Vitamin D and Multiple Health Outcomes: An Umbrella Review of Observational Studies, Randomized Controlled Trials, and Mendelian Randomization Studies.Adv Nutr. 2022 Aug 1;13(4):1044-1062. doi: 10.1093/advances/nmab142. Adv Nutr. 2022. PMID: 34999745 Free PMC article. Review.
References
-
- Pludowski P., Holick M.F., Pilz S., Wagner C.L., Hollis B.W., Grant W.B., Shoenfeld Y., Lerchbaum E., Llewellyn D.J., Kienreich K., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 2013;12:976–989. doi: 10.1016/j.autrev.2013.02.004. - DOI - PubMed
-
- Schottker B., Jorde R., Peasey A., Thorand B., Jansen E.H., Groot L., Streppel M., Gardiner J., Ordonez-Mena J.M., Perna L., et al. Vitamin D and mortality: Meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ. 2014;348:g3656. doi: 10.1136/bmj.g3656. - DOI - PMC - PubMed
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
